Doctor Carly Adamson
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
Outcomes related to IGFBP-7 in patients with heart failure and reduced ejection fraction and effects of dapagliflozin: findings from DAPA-HF
Event: ESC Congress 2022
Topic: Biomarkers
Session: SGLT2 inhibitors: pearls from recent trials and surveys
Alkaline phosphatase and bilirubin combined are a powerful predictor of outcome in patients with heart failure and reduced ejection fraction: an analysis of the ATMOSPHERE and PARADIGM-HF trials
Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic heart failure - Prognosis and prediction of outcome
ESC 365 is supported by
